Pittsburgh, PA, United States of America

Thar Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 12

% Expired Patents = 91.7


Forward Citations = 288

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Ning Shan (11 out of 19 patents)

silverMedal Miranda L Cheney (11 out of 15 patents)

bronzeMedal David R Weyna (10 out of 15 patents)

4.  Mazen Hanna (9 out of 15 patents)

5.  Raymond K Houck (4 out of 20 patents)

6.  Mazen H Hanna (3 out of 10 patents)

7.  Paul Isbester (1 out of 21 patents)

8.  Xufeng Sun (1 out of 3 patents)

9.  George Townend (1 out of 1 patent)

10.  David Weyna (0 patent)

11.  Miranda Cheney (0 patent)


12 patents:

Company Overview
Thar Pharmaceuticals, Inc. is a biopharmaceutical company based in Pittsburgh, PA, specializing in the development of innovative therapies for various medical conditions. The organization focuses on leveraging advanced drug delivery systems and formulation technologies to enhance the efficacy and safety of pharmaceutical products. With a commitment to research and development, Thar Pharmaceuticals aims to address unmet medical needs through its cutting-edge solutions and collaborations within the healthcare sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#166 in Pittsburgh, PA

#930 in Pennsylvania

#25,589 in US

#48,235 in the World

Pittsburgh, PA (US)
Pittsburgh, PA, United States of America
Forward Citations = 288

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Thar Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/thar-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…